Brokerage firm UBS has initiated coverage on consumer hygiene major Eureka Forbes Ltd. assigning a 'buy' rating with a target price of Rs 640. Shares of Eureka Forbes rose as much as 3% with the stock trading at Rs 450.40 apiece on Friday.
UBS describes the company as a steady earnings compounder, supported by a resilient business model and consistent financial performance.
According to the brokerage, Eureka Forbes stands out as a focused consumer hygiene company with a long runway for growth, supported by rising demand for clean water, healthier homes, and improved living standards across India.
UBS believes that the penetration across large home appliances, such as washing machines, refrigerators and televisions, has risen meaningfully over the past decade in India, driven by accelerating growth in gross disposable incomes and improving affordability. Even within cooling appliances, room air conditioners - once considered discretionary - have structurally increased penetration as income thresholds and usage economics improved.
UBS, in its latest brokerage note, believes water purifiers are now at a similar penetration inflection point. Despite water purifiers being a critical health-linked appliance, their penetration in India remains materially lower than for other large appliances and well below those of global peer markets.
This low base contrasts sharply with an increasingly supportive macro backdrop, characterised by rising urbanisation, sustained income growth, improving housing quality and higher female labour force participation factors that have historically preceded sharp penetration upcycles in other household durables, noting these factors collectively reinforce the company's leadership and pricing power.
On valuation, UBS notes that Eureka Forbes trades in line with the broader consumer durables sector, making its risk‑reward profile attractive given its compounding potential and long-term industry tailwinds.
With these strengths, UBS expects Eureka Forbes to continue delivering stable growth while capitalising on its dominant position in consumer hygiene solutions.
All of 14 analysts tracking the company maintain a 'buy' rating on the stock, according to Bloomberg data. The average 12-month consensus price target of Rs 699.06 implies an upside of 57%.
ALSO READ: Eureka's FY30 Goal: Twofold Revenue On Back Of 17x Profit Surge In Three Years
Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.